A Companion Diagnostic (CDx) supports personalized medicine in Japan by identifying genetic mutations in patients. These insights help clinicians select the most effective, personalized treatments, particularly in oncology. CDx also predicts the likelihood of adverse reactions, ensuring safer and more efficient therapeutic strategies, thereby improving patient outcomes.
